RxDoctor Payments Data

Jane Gladfelter

Medical · Houston, TXNPI 1710223649

Payments from drug & device makers

$1,980in general payments, 2019–2025

Across 103 payments — averaging $19.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$512
  • AstraZeneca$317
  • Amarin Pharma, Inc.$266
  • Takeda Pharmaceuticals U.S.A., Inc.$177
  • AbbVie$95
  • Biohaven Pharmaceuticals, Inc.$87
  • plus $525 from 15 others

What the payments were for

  • Food & beverage$1,980100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,980 in reported general payments places this provider in the 65th percentile of 1,490 medical providers in Texas.

See all medical providers in Texas

Other medical in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →